Information de reference pour ce titreAccession Number: | 00005531-199702150-00011.
|
Author: | Haverkate, Frits; Thompson, Simon G; Pyke, Stephen D M; Gallimore, Ruth J; Pepys, Mark B
|
Institution: | Gaubius Laboratory TNO-PG, PO Box 2215, 2301 CE Leiden, Netherlands (F Haverkate PhD); Medical Statistics Unit, School of Hygiene and Tropical Medicine (S G Thompson DSc, S D M Pyke MSc), and Immunological Medicine Unit, Royal Postgraduate Medical School (J R Gallimore BSc, Prof M B Pepys FRCP), London, UK. Correspondence to: Dr Frits Haverkate. for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group; Participants listed at end of paper.
|
Title: | Production of C-reactive protein and risk of coronary events in stable and unstable angina.[Report]
|
Source: | Lancet. 349(9050):462-466, February 15, 1997.
|
Abstract: | Summary: Background Inflammation is an important feature of atherosclerotic lesions, and increased production of the acute-phase reactant, C-reactive protein (CRP), is associated with a poor prognosis in severe unstable angina. We have investigated the existence and possible significance of the acute-phase responses of CRP and another sensitive reactant, serum amyloid A protein (SAA), in patients with unstable or stable angina.
Methods We used new ultrasensitive immunoassays to measure CRP and SAA concentrations in plasma from 2121 outpatients with angina (1030 unstable, 743 stable, the rest atypical) enrolled in the European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Study.All patients underwent coronary angiography and extensive clinical and laboratory assessment at study entry, and were then followed up for 2 years. All suspected coronary events during follow-up were reviewed by an independent endpoint committee.
Findings 75 individuals (41 with unstable, 29 with stable, and 5 with atypical angina) had a coronary event during follow-up. Concentrations of CRP at study entry were associated with coronary events in patients with stable or unstable angina: there was about a two-fold increase in the risk of a coronary event in patients whose CRP concentration was in the fifth quintile (>3.6 mg/L), compared with the first four quintiles. A third of the events occurred among patients who had a CRP concentration of more than 3.6 mg/L. CRP concentrations were positively correlated with age, smoking, body-mass index, triglycerides, extent of coronary stenosis, history of myocardial infarction, and lower ejection fraction. By contrast, concentrations of SAA were not associated with risk of a coronary event.
Interpretation We found that raised circulating concentrations of CRP are predictors of coronary events in patients with stable or unstable angina.The modest acute-phase responses of CRP were probably not the result of myocardial necrosis. Whatever the underlying mechanisms, the sensitive measurement of CRP as a prognostic marker may be useful in the management of coronary heart disease.
Lancet 1997; 349: 462-66.
Copyright. (C) The Lancet Ltd, 1997.
|
References: | 1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-09.
2. Bhakdi S, Dorweiler B, Kirchmann R, et al. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J Exp Med 1995; 182: 1959-71.
3. Mattila KJ, Nieminen MS, Valtonen V, et al. Association between dental health and acute myocardial infarction. BMJ 1989; 298: 779-81.
4. Hendrix MGR, Daemen M, Bruggeman CA. Cytomegalovirus nucleic acid distribution within the human vascular tree. Am J Pathol 1991; 138: 563-67.
5. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273-78.
6. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391-94.
7. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-14.
8. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34: 141-212.
9. Pepys MB. Acute phase proteins in the acute response. London: Springer-Verlag, 1989.
10. Shine B, de Beer FC, Pepys MB. Solid phase radioimmunoassays for C-reactive protein. Clin Chim Acta 1981; 117: 13-23.
11. Wilkins J, Gallimore JR, Tennent GA, et al. Rapid automated enzyme immunoassay of serum amyloid A. Clin Chem 1994; 40: 1284-90.
12. Pepys MB. The acute phase response and C-reactive protein. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford textbook of medicine, third edition. Oxford: Oxford University Press, 1995: 1527-33.
13. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91: 1351-57.
14. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
15. Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemostas 1995; 73: 374-78.
16. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive 168-72.
17. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-41.
18. Grossman W. Cardiac catheterization and angiography. Philadelphia: Lea and Febiger, 1986.
19. ECAT Angina Pectoris Study Group. ECAT Angina Pectoris Study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993; 14: 8-17.
20. Jespersen J, Bertina RM, Haverkate F. ECAT assay procedures: a manual of laboratory techniques. Dordrecht: Kluwer Academic Publishers, 1992.
21. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: 1-30.
22. Maseri A, Biasucci LM, Liuzzo G. Inflammation in ischaemic heart disease. BMJ 1996; 312: 1049-50.
23. Liuzzo G, Biasucci LM, Rebuzzi AG, et al. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 1996; 94: 2373-80.
24. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross-sectional study. BMJ 1996; 312: 1061-65.
25. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82: 513-20.
26. Pepys MB, Rowe IF, Baltz ML. C-reactive protein: binding to lipids and lipoproteins. Int Rev Exp Pathol 1985; 27: 83-111.
27. Volanakis JE, Narkates AJ. Interaction of C-reactive protein with artificial phosphatidyl-choline bilayers and complement. J Immunol 1981; 126: 1820-25.
28. Volanakis JE. Complement activation by C-reactive protein complexes. Ann N Y Acad Sci 1982; 389: 235-50.
29. van Leeuwen MA, van Rijswijk MH, van der Heijde DMFM, et al. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol 1993; 32 (suppl 3): 9-13.
30. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart-disease in the MRFIT nested case control study. Am J Epidemiol 1996; 144: 537-47.
|
Language: | English.
|
Document Type: | Early Report.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0140-6736
|
NLM Journal Code: | 2985213r, l0s, 0053266
|
Annotation(s) | |
|
|